Rochelle Nicole Ramos

Ms. Rochelle Nicole Ramos

Mapúa University, Manila, Philippines
+1
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in International Journal of Disaster Risk Reduction
Verified
Journal Article
Closed access
AOArdvin Kester S. Ong
Ardvin Kester S. Ong
Yogi Tri PrasetyoYogi Tri Prasetyo
Yogi Tri Prasetyo
FLFae Coleen Lagura
Fae Coleen Lagura
RRRochelle Nicole Ramos
Rochelle Nicole Ramos
KSKeenan Mark Sigua
Keenan Mark Sigua
ARAnak Agung Ngurah Perwira Redi
Anak Agung Ngurah Perwira Redi

19 July 2022 in Public Health in Practice
Verified
Journal Article
Open access
AOArdvin Kester S. Ong
Ardvin Kester S. Ong
Yogi Tri PrasetyoYogi Tri Prasetyo
Yogi Tri Prasetyo
FLFae Coleen Lagura
Fae Coleen Lagura
RRRochelle Nicole Ramos
Rochelle Nicole Ramos
JSJose Ma Luis Salazar
Jose Ma Luis Salazar
KTKriengkrai Thana
Kriengkrai Thana
Vaccines are utilized to prevent the severity of illnesses like the COVID-19 virus. Currently, there are a lot of COVID-19 vaccines available in the market like Pfizer, Moderna, AstraZeneca, Johnson and Johnson, and Sinovac. This research aimed to analyze the preference on the existing vaccine attributes of COVID-19. Specifically, this study considered 7 attributes such as cost, brand, recommendations, efficacy, side effects, vaccine type, and dose. A conjoint analysis with orthogonal design was utilized and 865 respondents were participated. The result showed that consumers considered brand as the highest attribute, specifically Pfizer and Moderna among other brands. Moreover, the efficacy of 90% and higher were the preferred vaccine with 1 in 100 patient side effects reported. It was seen that safety and effectiveness is the priority in choosing a COVID-19 vaccine. Interestingly, the knowledge and understanding of the COVID-19 vaccine was found to drive consumer's preference for the vaccines available. The findings of this study could be utilized by the government to increase the willingness to be vaccinated. Lastly, the result of this study would pave a way to promote herd immunity to help fight the COVID-19 pandemic worldwide.